Human Variome Project

Human Variome Project
Name	Human Variome Project
Type	International scientific consortium
Founded	2006
Headquarters	Melbourne, Australia
Founders	Peter Taschner; Richard Cotton
Area served	Global
Focus	Genetic variation data sharing

Human Variome Project The Human Variome Project is an international consortium established to collect, curate, and share information about human genetic variation associated with disease. It coordinates efforts among clinical laboratories, research institutions, patient organizations, and public health agencies to improve diagnosis, treatment, and genetic counseling worldwide. The initiative interacts with major genomics programs, rare disease networks, and regulatory bodies to standardize variant interpretation and data exchange.

Overview

The initiative brings together stakeholders from institutions such as World Health Organization, National Institutes of Health, European Molecular Biology Laboratory, Wellcome Trust, Centers for Disease Control and Prevention, American College of Medical Genetics and Genomics, European Society of Human Genetics, and Global Alliance for Genomics and Health to harmonize variant databases and reporting. It aligns with large-scale projects like 1000 Genomes Project, Human Genome Project, Genome-wide Association Study consortia, and national efforts including All of Us Research Program, UK Biobank, Genomics England, and China National GeneBank. Collaboration also involves patient advocacy groups such as Genetic Alliance, EURORDIS, and Cystic Fibrosis Foundation.

History and Development

Conceived in the mid-2000s, the consortium emerged amid advances by groups like International HapMap Project and leaders affiliated with Peter Taschner and Richard Cotton. Early meetings involved representatives from Australian National University, Royal Melbourne Hospital, European Commission, National Human Genome Research Institute, and philanthropic funders including Wellcome Trust and Bill & Melinda Gates Foundation. The project evolved through workshops held at venues associated with Cold Spring Harbor Laboratory, European Molecular Biology Organization, and Institute of Genetics and Molecular Medicine. Milestones included establishing variant curation guidelines interacting with efforts from American College of Medical Genetics and Genomics and publications in journals linked to Nature Genetics and The Lancet.

Goals and Scope

Primary objectives include comprehensive aggregation of pathogenic and likely pathogenic variants, development of curation standards, and promotion of global interoperability. The scope spans rare disease loci investigated by consortia like International Rare Diseases Research Consortium and common disease variants reported by cohorts such as Framingham Heart Study and Rotterdam Study. It seeks to integrate clinical laboratory data from networks including ClinGen, DECIPHER, LOVD, and national reference laboratories tied to National Health Service (England), Australian Genomics Health Alliance, and Canadian Open Genetics Repository.

Organizational Structure and Governance

Governance encompasses an international steering committee with representatives from academic centers like Harvard Medical School, University of Cambridge, University of Oxford, Karolinska Institutet, and University of Tokyo. Operational arms coordinate regional variant curation networks in collaboration with entities such as Asia-Pacific Economic Cooperation, African Academy of Sciences, Pan-American Health Organization, and European Commission Directorate-General for Research and Innovation. Policies reflect engagement with regulatory authorities including Food and Drug Administration and European Medicines Agency and standard-setting bodies such as International Organization for Standardization.

Data Collection, Standards, and Databases

The consortium advocates standardized variant representation using nomenclature systems created by Human Genome Organisation, Human Genome Variation Society, and data models influenced by Global Alliance for Genomics and Health. It interoperates with databases including ClinVar, dbSNP, dbGaP, European Nucleotide Archive, Genome Aggregation Database, LOVD, and clinical repositories managed by institutions like Mayo Clinic, Johns Hopkins University, and Karolinska University Hospital. Technical standards draw on work from Global Alliance for Genomics and Health APIs, HL7 clinical data models, and ontologies developed at National Center for Biomedical Ontology and Open Biological and Biomedical Ontology Foundry.

Ethical, Legal, and Social Issues

The project addresses privacy, consent, and data-sharing policies in dialogue with organizations such as World Medical Association, Council of Europe, UNESCO, European Data Protection Board, and national bodies like Office for Human Research Protections. Ethical frameworks reference guidance from Declaration of Helsinki, Universal Declaration on the Human Genome and Human Rights, and case law from jurisdictions including United States Supreme Court and European Court of Human Rights. It navigates implications for insurance regulation exemplified by laws like Genetic Information Nondiscrimination Act and engages with patient consent models developed by Genetic Alliance and National Institutes of Health.

Impact and Applications

Practical applications include improved molecular diagnosis at clinical centers such as Great Ormond Street Hospital, enhanced newborn screening programs associated with American Academy of Pediatrics, and oncology variant interpretation used by institutions like MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Research enabled by aggregated variant data supports drug development by companies including GlaxoSmithKline, Roche, Novartis, and informs public health genomics initiatives led by Public Health England and Centers for Disease Control and Prevention. The consortium's work underpins translational projects linking biobanks such as Icelandic deCODE genetics and precision medicine programs at Mayo Clinic and Cleveland Clinic.

Category:Genetics